telehealth.helpFind my match

Home Weight loss (GLP-1) By state Nebraska

Nebraska's Stalled GLP-1 Bill: 8 programs ship to NE

Nebraska lawmakers looked at Medicaid coverage for weight-loss drugs in 2024 and stopped at the price tag. The bill was shelved, Heritage Health still says no for weight loss alone, and the state employee plan says no too, even after a 2026 change of insurer. Here is where that leaves Nebraskans, and the cash prices that now beat the old list price. The lowest price we found from a program that ships to Nebraska: compounded semaglutide at $89 a month on a 12-month plan ($99 month to month) at Lttl.

  • Updated
  • Prices read Nov 12, 2026

Nebraska at a glance

Nebraska Medicaid
Does not cover for weight loss
State employee plan
Does not cover for weight loss
Adults with obesity
36% (2025)
Programs we compare that ship to NE
8 of 22

Online GLP-1 programs for Nebraska, cheapest first

Programs that ship to Nebraska. Prescribed online by a licensed clinician; medication and delivery included.

How we pick and check programs

Our pick for November 2026

Daily oral plan
Intro offer: from $7 a day

A daily oral GLP-1 plan. No needles, no injections

GLP-1 protocol from$199/moon the 3-month plan with the $100 welcome credit ($299 without), shipped monthly; the home page names no form for this plan (the oral offer is from $7 a day)
Visit HumeCare Read our HumeCare review

Compounded semaglutide in Nebraska: lowest monthly price

#ProgramLowest priceMonth to monthLink
1LttlCheapest$89/mo 12-month plan$99 / 4 wksVisitLttl
2BetterMe Rx$99/mo 12-month plan$199/moVisitBetterMe Rx
3Refills$99/mo $99 / 4 wksVisitRefills
4Direct Meds$297/mo $297/moVisitDirect Meds
5GalaFrom $69/mo starting price, plan length not statedNot statedVisitGala
6TrimRxFrom $349/mo starting price, plan length not statedNot statedVisitTrimRx

Compounded tirzepatide in Nebraska: lowest monthly price

#ProgramLowest priceMonth to monthLink
1MaximusCheapest$99.99/mo 12-month planNot offeredVisitMaximus
2Lttl$139/mo 12-month plan$149 / 4 wksVisitLttl
3BetterMe Rx$159/mo 12-month plan$249/moVisitBetterMe Rx
4Refills$159/mo $159 / 4 wksVisitRefills
5Direct Meds$399/mo $399/moVisitDirect Meds
6GalaFrom $99/mo starting price, plan length not statedNot statedVisitGala
7TrimRxFrom $279/mo starting price, plan length not statedNot statedVisitTrimRx
  1. Low month-to-month#1
    Up to $140 off your first month

    Compounded semaglutide for $99, month to month

    Semaglutide$99/momonth to month (4-week supply); $89 on a 12-month plan
    Visit Lttl Read our Lttl review
  2. Pills or shots#2
    Semaglutide from $99/mo

    Choose weekly shots or daily tablets; shots from $99/mo on the 12-month plan

    Semaglutide shots from$99/moon the 12-month plan; $199 month to month
    Visit BetterMe Rx Read our BetterMe Rx review
  3. No contract#3
    Fall sale: 40% off

    Compounded semaglutide as low as $99 a month

    Semaglutide as low as$99/moper 4-week supply, month to month; shown during a 40% fall sale
    4.2 on Trustpilot1,779 reviews ·
    Visit Refills Read our Refills review
  4. Low-cost tirzepatide#4
    Same price at every dose

    Compounded tirzepatide from $99.99 a month

    Tirzepatide from$99.99/moon the 12-month plan, paid up front; $199.99 on 2 months
    4.4 on Trustpilot1,106 reviews ·
    Visit Maximus Read our Maximus review
  5. Delivery in 1-2 days#5
    Fall sale: $150 off

    Same price at every dose, at your door in 1-2 days

    Semaglutide$297/momonth to month: medication, doctor visits and shipping included; tirzepatide $399; fall sale: "starting at $147", "$150 off"
    4.5 on Trustpilot17,724 reviews ·
    Visit Direct Meds Read our Direct Meds review

3 more programs are in the price tables above.

Nebraska in 2026: three plans, one answer for weight loss

Heritage Health, Nebraska's Medicaid managed care program, does not cover GLP-1s for weight loss alone, and KFF's January 2026 review lists Nebraska among the states without Medicaid obesity coverage. Diabetes coverage continues with prior authorization. If your doctor is prescribing a GLP-1 for type 2 diabetes, that request follows a separate, older path.

State employees get the same answer. The state's 2026-2027 open enrollment FAQ answers "No" to whether weight-loss drugs, including GLP-1s, are covered. That held even as the state moved to a new partnership with Blue Cross and Blue Shield of Nebraska for the plan year that began July 1, 2026, after an open enrollment that ran May 5 to 19. Commercial plans set their own rules, and employers can leave out the obesity benefit, so ask HR before you assume.

That leaves cash for Nebraskans without coverage. The gap between list price and cash price is wide now. Online programs licensed in Nebraska sell compounded semaglutide and tirzepatide with medication and shipping in the monthly price (ask whether the visit is included), and Maximus also sells brand-name Wegovy and Zepbound here. They ship from Omaha to the Panhandle. Some keep the same price at every dose, so the cost stays steady as treatment goes on.

  • Nebraska Medicaid does not cover GLP-1s for obesity (KFF, January 2026). (kff.org)
  • The Nebraska DAS 2026-2027 open enrollment FAQ says there is no coverage for weight-loss GLP-1s for state employees. (web.archive.org)
  • 36.0% of Nebraska adults had obesity in 2025 (CDC). (cdc.gov)
  • LB907 (2024), introduced by Sen. Merv Riepe to require Nebraska Medicaid coverage of obesity treatment including anti-obesity drugs, was heard February 15, 2024 and indefinitely postponed April 18, 2024. (nebraskalegislature.gov)
  • The State of Nebraska and Blue Cross and Blue Shield of Nebraska began a new partnership with the plan year starting July 1, 2026; open enrollment ran May 5-19, 2026. (das.nebraska.gov)
  • 34.2% of Nebraska's Medicare beneficiaries were in Medicare Advantage in 2025, and 25.6% in non-metro counties (RUPRI analysis of CMS data). (rupri.public-health.uiowa.edu)
  • CMS's GLP-1 Bridge (July 1, 2026 - December 31, 2027) gives eligible Part D enrollees Wegovy, Foundayo or the Zepbound KwikPen at a $50 copay; it requires prior authorization and a BMI of 35+, or lower with set conditions. (cms.gov)
  • Nebraska's 2026-2027 state employee pharmacy benefit is run by BCBS Prime on the NetResults Biosimilar Plus (PDL 25) list; weight-loss drugs, including GLP-1s, are not covered, also not for sleep apnea, and GLP-1s are covered for type 2 diabetes with preauthorization. (web.archive.org)

LB907: Sen. Riepe's 2024 try, and why it went nowhere

State Sen. Merv Riepe of Ralston introduced LB907 on January 4, 2024. It would have required Nebraska Medicaid to cover obesity treatment, including intensive behavioral therapy and FDA-approved anti-obesity drugs such as the GLP-1s. The Health and Human Services Committee heard it on February 15, 2024, and the bill was indefinitely postponed on April 18, 2024, which ended it.

Cost drove the outcome. The Department of Health and Human Services' estimate ran into the hundreds of millions over two years, while the Legislative Fiscal Office's estimate was far lower. Supporters argued real use would be far lower, since only a small share of eligible patients start these drugs in states that cover them. We found no newer bill. Until one passes, Medicaid members who want a GLP-1 for weight loss alone are on the cash route.

Medicare in Nebraska: why the Bridge runs through Part D here

Nebraska retirees are less likely than most Americans to be in Medicare Advantage. A RUPRI analysis of CMS data put Nebraska at 34.2% in 2025, and only 25.6% in rural counties. Most Nebraskans on Medicare therefore have Original Medicare, and those with drug coverage usually get it from a separate Part D plan.

Part D coverage is what makes them eligible for the federal GLP-1 Bridge. From July 1, 2026 to December 31, 2027, eligible members can get Wegovy, Foundayo or the Zepbound KwikPen for a $50 copay with prior authorization. CMS sets BMI rules: 35 or more, or lower thresholds with certain heart, kidney or blood sugar conditions. People with type 2 diabetes stay on their regular Part D benefit. Your prescriber files the Bridge prior authorization with CMS's central processor; ask your doctor's office before you pay cash.

What Nebraska's new Blue Cross pharmacy plan says about GLP-1s

The state's move from UnitedHealthcare to Blue Cross and Blue Shield of Nebraska on July 1, 2026 came with a separate pharmacy contract. DAS put medical and pharmacy out to bid separately, and the pharmacy award went to BCBS Prime. The drug list for the new plan year is NetResults Biosimilar Plus (PDL 25), and it applies to both medical plan options.

The open enrollment FAQ answers the GLP-1 questions in a few words. Weight-loss drugs, GLP-1s included, are not covered. They are not covered for sleep apnea either. GLP-1s are covered for type 2 diabetes, with preauthorization. If a drug is not on the list, the ordering physician can file an online formulary exception request, though approval is not guaranteed. For a state worker who wants a GLP-1 for weight alone, that leaves a cash program.

GLP-1 in Nebraska: questions

Does Nebraska Heritage Health cover Wegovy for weight loss?

No. Heritage Health plans follow the state drug list, which does not cover GLP-1s for weight loss alone. GLP-1s for type 2 diabetes are covered with prior authorization. A 2024 bill to add obesity coverage did not pass. Members who want a GLP-1 for weight loss usually pay cash, as compared on this page.

Why doesn't Nebraska Medicaid cover weight-loss drugs?

Mainly cost. When LB907 proposed coverage in 2024, the state health department's cost estimate was high, and the bill was indefinitely postponed in April 2024. We found no newer bill. That could change, but for now the practical route for Medicaid members is a cash program.

Do Nebraska state employees get GLP-1s covered for weight loss?

No. The state's 2026-2027 open enrollment FAQ answers "No" to whether weight-loss drugs, including GLP-1s, are covered. GLP-1s are covered for type 2 diabetes, with preauthorization. State workers can compare online programs below, where the monthly price includes the medication and shipping.

How fast can I start a GLP-1 online in Nebraska?

You fill out a health form or have a video visit with a clinician licensed in Nebraska. Once approved, your first shipment goes out by mail. Some programs ask for recent labs first. The programs on this page are confirmed to serve Nebraska.

What does semaglutide cost in Nebraska without insurance?

Compounded semaglutide from online programs usually costs far less than the brand, and many keep one price as the dose rises. In November 2026 Lttl sold it for $99 month to month and BetterMe Rx from $99 on a 12-month plan. Maximus sells the brand Wegovy pill for buyers who want it. Compare the price at your maintenance dose, plus any membership fee.

Did the switch to Blue Cross Blue Shield of Nebraska add GLP-1 coverage for state workers?

Not for weight loss. The state began its new partnership with Blue Cross and Blue Shield of Nebraska on July 1, 2026, and its 2026-2027 open enrollment FAQ says weight-loss drugs, including GLP-1s, are not covered, not even for sleep apnea. Diabetes use stays covered. State workers can compare the cash programs on this page.

Can Nebraska Medicare members get a GLP-1 for weight loss?

Possibly, through the federal GLP-1 Bridge from July 1, 2026 to December 31, 2027. Eligible Part D members can get Wegovy, Foundayo or the Zepbound KwikPen for a $50 copay with prior authorization and BMI rules. Most Nebraska Medicare members are not in Medicare Advantage, so most qualify through a stand-alone Part D plan; your prescriber files the request with CMS's Bridge processor.

See programs for Nebraska All states

Sources: kff.org · cdc.gov · web.archive.org